Table 6.
Study | Intervention | Comparator | Follow-up | n | Mucosal healing, RR (95%CI) | Quality of evidence |
Chande et al[23] | AZA | IFX | 26 wk | 214 | RR 0.55 (0.33-0.94)1 | Moderate |
Mucosal healing was defined as the absence of mucosal ulceration at week 26 in patients who had confirmed mucosal ulceration at baseline. AZA: Azathioprine; CI: Confidence interval; IFX: Infliximab; n: Number of patients; RR: Risk ratio.